ArticleBMC cancer2024

Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial.

Wuzhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.